Trial intelligence / Profile preview

Conbercept Timing Before Vitrectomy in PDR (CONCEPT)

NCT03506750Phase 4Unknown

Sponsor
Jiangsu Provincial People's Hospital
Start
Jun 2017
Primary completion
Sep 2018
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 4 trial of conbercept in proliferative diabetic retinopathy (PDR), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.

02

Drugs

conbercept
03

Conditions

proliferative diabetic retinopathy (PDR)

Beyond the preview

Go deeper on NCT03506750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03506750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call